Brief: Rhythm Biosciences Seeks Trading Halt
28/02/2023 23:23
March 1 (Reuters) - Rhythm Biosciences Ltd RHY.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON THERAPEUTIC
GOOD
ADMINISTRATION SUBMISSION
Source text for Eikon: ID:nASX3sdCX4
Further company coverage: RHY.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rhythm Biosciences
See all newsBrief: Rhythm Biosciences Says Gavin Fox-Smith Resigns As Chair
Brief: Rhythm Biosciences Announces Appointment Of Non-Executive Directors
Australia's Rhythm Biosciences rises on accelerating commercialisation of cancer test
Brief: Rhythm Biosciences Executes Distribution Agreement For Genetype
Brief: Rhythm Biosciences Seeks Trading Halt